Log in | Register

Home
All Journals
Expert Review of Pharmacoeconomics & Outcomes Research
List of Issues
Volume 23, Issue 3

Expert Review of Pharmacoeconomics & Outcomes Research

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 23, Issue 3 (2023)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 23, Issue 3 (2023)

See all volumes and issues

Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Perspective

Article

Bringing the patient’s perspectives forward in drug development and health-care evaluation

K A Meadows & M Reaney

Pages: 267-271

Published online: 10 Jan 2023

AbstractforBringing the patient’s perspectives forward in drug development and health-care evaluation | Full Text | References | PDF (207.8 KB) | EPUB

216 Views
1 CrossRef citations
0Altmetric

Systematic Review

Perspectives in prospective comparative economic evaluations: a systematic review

Pascale Guerre, Laure Huot, Cyrille Colin, Adrien Marrel & Hugo Rabier

Pages: 273-280

Published online: 19 Jan 2023

AbstractforPerspectives in prospective comparative economic evaluations: a systematic review | Full Text | References | PDF (2 MB) | EPUB

66 Views
0 CrossRef citations
0Altmetric

Systematic Review

Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review

Omer Ben-Aharon, Georgi Iskrov, Iftach Sagy & Dan Greenberg

Pages: 281-295

Published online: 24 Jan 2023

AbstractforWillingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review | Full Text | References | PDF (485.4 KB) | EPUB

134 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment

Mok Oh, Ali McBride, Sandipan Bhattacharjee, Marion Slack, Joanne Jeter & Ivo Abraham

Pages: 297-307

Published online: 29 Jan 2023

133 Views
0 CrossRef citations
0Altmetric

Article

The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention

Mok Oh, Ali McBride, Sandipan Bhattacharjee, Marion Slack, Joanne Jeter & Ivo Abraham

Pages: 309-316

Published online: 29 Jan 2023

151 Views
0 CrossRef citations
0Altmetric

Article

The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer

Mok Oh, Ali McBride, Sandipan Bhattacharjee, Marion Slack, Joanne Jeter & Ivo Abraham

Pages: 317-325

Published online: 03 Feb 2023

70 Views
0 CrossRef citations
0Altmetric

Article

Adherence to augmentation therapy for the treatment of major depressive disorder

Felicia Forma, Joshua N. Liberman, Pinyao Rui & Charles Ruetsch

Pages: 327-335

Published online: 26 Jan 2023

AbstractforAdherence to augmentation therapy for the treatment of major depressive disorder | Full Text | References | PDF (2.3 MB) | EPUB

865 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China

Fangjian Shang, Boyuan Zhang & Shuo Kang

Pages: 337-343

Published online: 24 Jan 2023

209 Views
0 CrossRef citations
0Altmetric

Article

Budget impact analysis of daratumumab for light-chain amyloidosis in Cyprus

Panagiotis Petrou

Pages: 345-351

Published online: 12 Feb 2023

AbstractforBudget impact analysis of daratumumab for light-chain amyloidosis in Cyprus | Full Text | References | PDF (1.2 MB) | EPUB

553 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile

Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Balmaceda, Federico Augustovski, Andres Pichon-Riviere & Ariel Bardach

Pages: 353-363

Published online: 31 Jan 2023

94 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore

Cheng Ean Chee et al.

Article | Published online: 22 May 2024

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

Sudewi Mukaromah Khoirunnisa et al.

Review Article | Published online: 20 May 2024

Open Access

Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review

Aziz Rezapour et al.

Review Article | Published online: 20 May 2024

Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration

Lada Leyens et al.

Review Article | Published online: 15 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Pharmacoeconomics & Outcomes Research (Vol.23, Iss.3, 2023)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?